再発・再燃卵巣癌に対する胸腔内・腹腔内化学療法およびホルモン療法 ―症例報告―
鍔本 浩志, 実 福岡, 原田 佳世子 et al. · 産婦人科の進歩 · 2009
Cited by 0 works. doi:10.11437/sanpunosinpo.61.41
Authors
References
- Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
- Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
- Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
- Malignant pleural effusion, current and evolving approaches for its diagnosis and management
- Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials
- Growth Inhibition of Human Ovarian Cancers by Cytotoxic Analogues of Luteinizing Hormone-Releasing Hormone
- Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515
- Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer
- Differential Regulation of Two Forms of Gonadotropin-Releasing Hormone Messenger Ribonucleic Acid in Human Granulosa-Luteal Cells**This work was supported by grants from the Medical Research Council of Canada.
- Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer